RTW INVESTMENTS, LP - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 114 filers reported holding ATHIRA PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2022$25,739,000
+3.6%
1,906,5570.0%0.53%
+46.8%
Q4 2021$24,842,000
+38.9%
1,906,5570.0%0.36%
+34.4%
Q3 2021$17,884,000
-8.4%
1,906,5570.0%0.27%
-8.5%
Q2 2021$19,523,000
-60.0%
1,906,557
-28.1%
0.30%
-61.3%
Q1 2021$48,807,000
-45.1%
2,652,553
-1.2%
0.76%
-48.9%
Q4 2020$88,899,000
+95.9%
2,685,779
+0.6%
1.49%
+36.6%
Q3 2020$45,372,0002,668,9131.09%
Other shareholders
ATHIRA PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders